SR11237
SR11237 (BMS-649) is a potent retinoid X receptor (RXR) -selective agonist that is devoid of any RAR activity. SR11237 can cause RXR/RXR homodimers to form and transactivate a reporter gene containing a RXR-response element[1][2][3].
Product Specifications
CAS Number
146670-40-8
Product Name Alternative
BMS-649
UNSPSC
12352005
Target
RAR/RXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sr11237.html
Purity
99.91
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC1(C2=CC(C3(C4=CC=C(C(O)=O)C=C4)OCCO3)=CC=C2C(C)(C)CC1)C
Molecular Formula
C24H28O4
Molecular Weight
380.48
References & Citations
[1]Gendimenico GJ, et al. A pleiotropic response is induced in F9 embryonal carcinoma cells and rhino mouse skin by All-trans-retinoic acid, a RAR agonist but not by SR11237, a RXR-selective agonist. J Invest Dermatol. 1994;102 (5) :676-680.|[2]Dupuis H, et al. Exposure to the RXR Agonist SR11237 in Early Life Causes Disturbed Skeletal Morphogenesis in a Rat Model. Int J Mol Sci. 2019;20 (20) :5198. Published 2019 Oct 20.|[3]H.L. Dupuis. The RXR agonist SR-11237 affects skeletal development. ABSTRACT ONLY| VOLUME 24, SUPPLEMENT 1, S147, APRIL 01, 2016.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![PE Anti-Human CD196/CCR6 Antibody[G034E3]](https://cdn.genprice.uk/products/763/68dd14b0061270361e7d3c9f/imageurl/e-ab-f1158d.webp)
E-AB-F1158D-03 2x 100 Tests
PE Anti-Human CD196/CCR6 Antibody[G034E3]
Sign In for Pricing
View Details 
